藥物開發
加速科學發展
在 BMS，每天在早期和後期發展的不同治療領域中，您都會受到有趣和有意義的工作啟發。我們透過臨床試驗、數據科學和策略營運，引領創新，為患者提供一流的藥物和療法。
在整個藥物開發階段都有機會能為您帶來挑戰。工作內容並不容易，但所做的事獨特又有趣。在這裡，您將改寫規則、解決最艱難的挑戰，並創造奇蹟。
Guiding the Vision for Drug Development
Living the mission of transforming patients’ lives through science, Drug Development leadership continue to inspire and be inspired by the incredible work happening now:
Meet our team
藥物開發職涯
BMS 的藥物開發部門提供多元化的職位，需要各種技能和專業知識。無論您對開發、數據科學、患者安全性或策略營運感興趣，都有機會為新藥的開發做出貢獻。
為治療癌症和血液疾病（包括細胞療法）等藥物開發工作做出貢獻。
支持免疫學、心血管和神經科學藥物的開發，好讓我們能為患者提供最佳療法。
利用資料和機器學習推動定量決策、加速藥物開發並改善患者結果。
利用營運科學成功地提供我們的藥物產品組合。
透過創新的全球監管策略和卓越的營運，合作為患者提供藥物，同時塑造監管科學和政策的未來。
管理我們的產品組合，優化和最大化公司的價值。
Our Areas of Focus
Development Hematology, Oncology, Cell Therapy (HOCT)
- Development Hematology, Oncology, Cell Therapy (HOCT)
- Development Immunology, Cardiovascular, Neuroscience (ICN)
- Global Biometrics & Data Sciences
- 全球發展營運
- 全球監管科學
- 產品組合與策略營運
- 全球患者安全性
Development Hematology, Oncology, Cell Therapy (HOCT)
In Hematology, Oncology, and Cell Therapy we are passionate about developing transformative therapies for patients with serious diseases. Our team executes with urgency to drive groundbreaking strategies, demonstrating exceptional scientific understanding of the underlying disease biology of clinical unmet need alongside deep technical development experience to deliver our broad hematology, oncology, and cell therapy portfolio. Our industry-leading team strives to unlock the full promise of our innovative treatments to help more patients, faster.
團隊位於： Boudry, Switzerland; California Bay Area; China, New Jersey, Seattle, WA
Development Immunology, Cardiovascular, Neuroscience (ICN)
The Immunology, Cardiovascular & Neuroscience Development organization aspires to develop and deliver innovative medicines to patients globally, addressing high unmet medical needs and transforming the lives of patients. Working cross-functionally in matrixed teams to accelerate development of new therapies, our focus on people empowers decision making at all levels of the organization.
團隊位於： Boudry, Switzerland; California Bay Area; Cambridge, MA; China; New Jersey; San Diego, CA
Global Biometrics & Data Sciences
The Global Biometrics and Data Sciences (GBDS) team provides value to R&D through their multifaceted support. Firstly, they support exploratory research design and analysis (EDTs) by collaborating in the exploration of biomarkers, utilizing a quantitative decision framework to progress assets from early to late stage (GT4), and in clinical development they support registrational study design and analysis (FDTs) by engaging regulators, responding to global Health Authorities, supporting publications/findings at medical congresses (e.g., ASCO), and informing/developing regulatory submissions. Lastly, the GBDS team ensures the appropriate scientific interpretation of data and asset value, expands upon clinical trial data to support key messages for payers and HCPs, and supports publications, Investigator Sponsored Research (ISRs), and Market Access needs (e.g., pricing and reimbursement). By providing these three areas of support, the GBDS team plays a critical role in advancing drug development and ensuring that our products are accessible to patients who need them.
團隊位於： Boudry, Switzerland; California Bay Area; Cambridge, MA; China; Hyderabad, India; New Jersey; San Diego, CA
全球發展營運
Conducting clinical trials is one of the company’s most critical pursuits to develop and bring new medicines to patients in need. Global Development Operations (GDO) leverages the science of clinical operations to plan, manage and execute BMS clinical trials across over 40 countries and 40 disease areas. GDO’s core strategy is to build and sustain superior clinical trial execution, collaborating and innovating on behalf of BMS patients and sites while never compromising on ethics, integrity, and compliance.
團隊位於： Boudry, Switzerland; China; Hyderabad, India; New Jersey; San Diego, CA
全球監管科學
Global Regulatory Sciences (GRS) serves as a trusted partner in delivering medicines to patients through innovative global regulatory strategies and operational excellence while shaping the future of regulatory science and policy.
團隊位於： Boudry, Switzerland; Hyderabad, India; New Jersey
產品組合與策略營運
The Portfolio & Strategic Operations Organization (P&SO) enables end-to-end portfolio strategy execution through integrated capabilities which drive strategic portfolio and business operational excellence through portfolio planning and reporting, resource management, strategic initiatives, clinical excellence, learning platforms and business continuity/risk management - as the business engine for Drug Development.
團隊位於： Boudry, Switzerland; California Bay Area; Cambridge, MA; China; New Jersey; San Diego, CA; Seattle, WA
全球患者安全性
At BMS, Worldwide Patient Safety (WWPS) is uniquely committed to safeguarding the patients we serve. Through industry leading pharmacovigilance and risk management capabilities, we ensure the safety profile of BMS medicines is well-characterized and our patients have access to trusted and reliable information to optimize their safe and informed use.
團隊位於： Boudry, Switzerland; China; New Jersey
我們在印度海德拉巴的技術與創新中心
BMS 海德拉巴是一處整合性全球研究中心，旨在透過建立永續且創新的解決方案，從而幫助患者戰勝嚴重疾病。我們在海德拉巴的發展部門，將協助建立重要能力來支援藥物生命週期的多個重要階段，包括監管、生物統計學、營運和臨床科學。這項工作將進一步加速我們的藥物開發，並促進 BMS 發現、開發和提供創新藥物以幫助患者的使命。
職涯故事
聽聽我們世界各地藥物開發團隊成員的故事，瞭解他們每天為患者所做的工作。
